Rashmi Kaul, PhD

Professor of Immunology

  • 725 Citations
  • 12 h-Index
1983 …2019
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Dr. Kaul's lab investigates how hormonal factors affect inflammation during Hepatitis C virus pathogenesis and liver cancer development. Her team also investigates the role of estrogen in regulation of inflammation during recurrent urinary tract infections by E. coli and also developing novel nanoparticle based therapy for killing intracellular bacteria or killing cancer cells.

Fingerprint Dive into the research topics where Rashmi Kaul is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Autoimmune Experimental Myasthenia Gravis Medicine & Life Sciences
Cholinergic Receptors Medicine & Life Sciences
MHC Class I Genes Medicine & Life Sciences
Nanodiamonds Chemical Compounds
Animal Disease Models Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
MHC Class II Genes Medicine & Life Sciences
Estrogen Receptors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2016 2017

Research Output 1983 2019

  • 725 Citations
  • 12 h-Index
  • 23 Article
  • 2 Review article
  • 1 Letter

Characteristics of carcinoembryonic antigen-producing colorectal cancers: A population based study

Groover, S., Kaul, R., Johnston, S. E., Zhao, Y. D., Karippot, A. & Thirunavukarasu, P., 1 Jan 2019, In : Archive of Oncology. 25, 1, p. 1-8 8 p.

Research output: Contribution to journalArticle

Open Access
Carcinoembryonic Antigen
Colorectal Neoplasms
Odds Ratio
Population
Neoplasms

Estrogen receptor subtype agonist activation in human cutaneous squamous cell carcinoma cells modulates expression of CD55 and cyclin D1

Lan, J., Gao, X. H. & Kaul, R., 1 Jan 2019, In : EXCLI Journal. 18, p. 606-618 13 p.

Research output: Contribution to journalArticle

Cyclin D1
squamous cell carcinoma
cyclins
Estrogen Receptors
agonists
2 Citations (Scopus)

Nanodiamonds facilitate killing of intracellular uropathogenic e. Coli in an in vitro model of urinary tract infection pathogenesis

Iyer, J. K., Dickey, A., Rouhani, P., Kaul, A., Govindaraju, N., Singh, R. N. & Kaul, R., 1 Jan 2018, In : PLoS ONE. 13, 1, e0191020.

Research output: Contribution to journalArticle

nanodiamonds
Nanodiamonds
urinary tract diseases
uropathogenic Escherichia coli
Uropathogenic Escherichia coli
10 Citations (Scopus)

Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis

Iyer, J. K., Kalra, M., Kaul, A., Payton, M. E. & Kaul, R., 7 Oct 2017, In : World Journal of Gastroenterology. 23, 37, p. 6802-6816 15 p.

Research output: Contribution to journalArticle

Chronic Hepatitis C
Estrogen Receptors
Hepacivirus
Hepatocellular Carcinoma
Liver
8 Citations (Scopus)

Purification and functionalization of nanodiamond to serve as a platform for amoxicillin delivery

Rouhani, P., Govindaraju, N., Iyer, J. K., Kaul, R., Kaul, A. & Singh, R. N., 1 Jun 2016, In : Materials Science and Engineering C. 63, p. 323-332 10 p.

Research output: Contribution to journalArticle

Nanodiamonds
Amoxicillin
purification
Purification
delivery